We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood

By LabMedica International staff writers
Posted on 19 Oct 2026

Food allergy is a major childhood health concern, and distinguishing persistent risk from transient sensitization can guide clinical decisions. More...

Specific IgE antibodies may be detectable even when a child has no symptoms after eating the implicated food, complicating interpretation. Yet detailed North American data on how these antibody responses change during early childhood have been limited.

To better characterize these changes, a new study tracked IgE sensitization patterns between infancy and age 5. The analysis focused on responses to allergen extracts and individual allergen components, assessing sensitization rather than confirmed clinical allergy. This longitudinal approach allowed the team to examine whether sensitization persisted, disappeared, or emerged later in childhood.

The researchers analyzed samples from 500 mother-child pairs enrolled in the Canadian CHILD Study, with blood collected from mothers during pregnancy and from children at ages 1 and 5. Testing covered approximately 300 allergen extracts and individual components, allowing the team to characterize how sensitization changed during early childhood.

Specific IgE sensitization was detected in 25.3% of children at age 1, rising to 40.4% by age 5. Egg and peanut were among the main food sensitizers in infancy, while peanut and tree nuts predominated at age 5. Over the same period, sensitization to environmental allergens, including cats, dogs, house dust mites, and grass pollen, also became more common.

Within these broader changes, peanut and tree nut sensitization followed distinct trajectories. Approximately half of children sensitized to major peanut components at 12 months remained sensitized at age 5. In contrast, sensitization to important components of cashew, hazelnut, walnut, and pistachio often emerged later in childhood.

Other responses diminished over time, with approximately one in four children losing sensitization to important 2S albumins during the four-year period. These proteins include major allergen components of peanut, tree nuts, and sesame and serve as useful markers for food allergies associated with systemic reactions.

Published in Allergy on September 16, 2026, the study involved the Department of Pediatric and Adolescent Medicine at University Hospital St. Pölten, a teaching and research site of Karl Landsteiner University of Health Sciences (Krems an der Donau, Austria), alongside Canadian universities and pediatric research centers, including the Hospital for Sick Children (SickKids; Toronto, Canada). 

The authors emphasized that oral food challenges were not performed to confirm clinical food allergy. The observed loss of sensitization therefore does not mean that one in four children outgrew an established food allergy.

“Especially in young children, a positive allergy test is not necessarily the end of the story. We need to know whether a sensitization persists, disappears or develops later. Looking at individual allergen components gives us valuable information for discussing risks and treatment options with families,” said Thomas Eiwegger, head of the Department of Pediatric and Adolescent Medicine at University Hospital St. Pölten.

Related Links
Department of Pediatric and Adolescent Medicine at University Hospital St. Pölten
Hospital for Sick Children


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.